A DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER CLINICAL TRIAL OF DONEPEZIL IN POSTERIOR CORTICAL ATROPHY DUE TO UNDERLYING ALZHEIMER’S DISEASE: DONIPAD STUDY

Basil H. Ridha,Sebastian Crutch,Dawn Cutler,Christopher Frost,William Knight,Suzie Barker,Norah Epie,Elizabeth K. Warrington,Riitta Kukkastenvehmas,Jane Douglas,Martin N. Rossor

Alzheimer's & dementia（2017）

引用 24|浏览11

暂无评分

摘要

The study investigated whether donepezil exerts symptomatic benefit in patients with posterior cortical atrophy (PCA), an atypical variant of Alzheimer’s disease.

查看译文

关键词

Posterior cortical atrophy,Alzheimer’s disease,Donepezil,Clinical trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要